Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors.
about
Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
Phase I and pharmacokinetic st ...... ve 5-imino-13-deoxydoxorubicin
@nl
type
label
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
Phase I and pharmacokinetic st ...... ve 5-imino-13-deoxydoxorubicin
@nl
prefLabel
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
Phase I and pharmacokinetic st ...... ve 5-imino-13-deoxydoxorubicin
@nl
P2093
P2860
P1476
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
P2093
Gerald M Walsh
James C Bigelow
Raymond J Hohl
Richard D Olson
Robert E Vestal
Sarah A Holstein
P2860
P2888
P304
P356
10.1007/S10637-015-0220-Z
P577
2015-02-21T00:00:00Z